Cross posted from Nature Medicine’s Spoonful of Medicine blog.
There’s growing concern over how pharmaceutical companies use social media and the Internet to market their products. Last November, the US Food and Drug Administration held a hearing on the topic, and many were worried over how marketing mediums such as Twitter — which has a 140-character limit on text — can sufficiently disclose drug risks.
The FDA asked for comment, and several pharmaceutical companies, advocacy groups and members of the public have since spoken up.
There’s plenty to say, apparently, about 140 characters.
While many of the commenters submitted lengthy reports with their ideas, we’ve condensed the information into — you guessed it — Twitter-size summaries.